Advertisement

Topics

C T O CLINICA TERAPUTICA OCULAR Company Profile

12:47 EST 21st November 2017 | BioPortfolio

Nil

Location

Rua Vitor Konder, 125 - 8ª andar - Centro
Florianópolis/SC
88015-400

Contact

Phone: (48) 3025 7001
Email: cto@ctoflorianopolis.com.br


News Articles [206 Associated News Articles listed on BioPortfolio]

Complete response letter from FDA received by Ocular Therapeutix

Biopharmaceutical company focused on the development, manufacture and commercialisation of therapies for ocular conditions, Ocular Therapeutix, has received a complete response letter regarding its r...

Mattessich Starts as New Ocular CEO, Trims Staff in Cost-Saving Move

Antony Mattessich has formally started as CEO of Ocular Therapeutix and his first move as top executive is culling the company’s headcount by 19 percent. Bedford, MA-based Ocular (NASDAQ: OCUL), who...

Ocular cuts jobs post FDA rejection

Ocular Therapeutix has announced it is laying off 19% of its workforce in order to cut operating expenses.

Ocular Analyzes Particulates Root Cause After Whiffing With Steel Blade

Ocular takes another swing at resolving the manufacturing issues that resulted in a complete response letter for its Dextenza.    

Ocugen’s treatment for ocular graft-versus-host disease gets orphan drug designation

The FDA has granted orphan drug designation for OCU300 to treat ocular graft-versus-host disease, according to a press release from Ocugen. Ocular graft-versus-host disease affects 40% to 60% of patie...

Ocular Therapeutix tumbles on further FDA delay for Dextenza

Ocular Therapeutix says it received a Complete Response Letter (CRL) from the US Food and Drug Administration…

Pomerantz LLP: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ocular Therapeutix, Inc. of Class Action Lawsuit and Upcoming Deadline - OCUL

NEW YORK, NY / ACCESSWIRE / July 14, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Ocular Therapeutix, Inc. ("Ocular" or the "Company") (NASDAQ: OCUL) and certai...

Another regulatory hit for Ocular, US FDA rejects eye drug

The US FDA has rejected Ocular Therapeutix’s eye pain treatment Dextenza for a second time, again citing concerns about how the drug is made and tested.

PubMed Articles [755 Associated PubMed Articles listed on BioPortfolio]

Ocular involvement in patients with spondyloarthritis.

Ocular inflammatory diseases can present as isolated conditions but also as part of systemic inflammatory diseases. Anterior uveitis is closely related to SpA and shares the common genetic background ...

Systematic analysis of ocular trauma by a new proposed ocular trauma classification.

The current classification of ocular trauma does not incorporate adnexal trauma, injuries that are attributable to a nonmechanical cause and destructive globe injuries. This study proposes a new class...

Ocular Syphilis: An Update.

This review aims to provide an update on the clinical presentation, diagnosis, and treatment of ocular syphilis. While ocular syphilis is not a new phenomenon, recent resurgence in the incidence of ov...

Ocular surface lubricants.

The purpose of this article is to provide an overview of the ocular lubricants currently available, consider the components of the various formulations and highlight the status of preservative use in ...

Echinocandins in Ocular Therapeutics.

Fungal infections of the eye, especially fungal keratitis and endophthalmitis, are major causes of concern and if left untreated could lead to vision loss. Currently, natamycin (polyene antifungal) is...

Clinical Trials [683 Associated Clinical Trials listed on BioPortfolio]

Using Probiotics to Reactivate Tumor Suppressor Genes in Colon Cancer

The purpose of the study is to determine if probiotic bacteria have a beneficial effect on the colon cancer-associated microbiota and epigenetic alterations in colon cancer. Dietary supple...

Surveillance of Ocular Surface Flora (SURFACE)

Topical fluoroquinolones (FQs) have achieved widespread use in ophthalmology for both the treatment and prophylaxis of ocular infections. The present study is set to determine the bacteri...

The Effects of LycoRed Phytonutrient and Vitamin Supplement (a.k.a. LYC-001e) on Ocular Blood Flow

Objectives: To determine LYC-001e's influences on ocular blood flow Ocular blood flow has been implicated as a parameter relevant to eye health and involved in the disease process of sever...

Ciracadian Ocular Perfusion and Ocular Blood Flow

Compare the short term effects of two IOP-lowering medications on ocular perfusion pressure, ocular blood flow, circadian IOP and blood pressure in patients with glaucoma.

OVEMP in Myasthenia

Myasthenia gravis is an autoimmune disorder of neuromuscular transmission, characterized by fluctuating muscle weakness and fatigability. In isolated ocular myasthenia, when only the extra...

Companies [71 Associated Companies listed on BioPortfolio]

C T O CLINICA TERAPUTICA OCULAR

Nil

Ocular Therapeutix, Inc. 

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of t...

Ora, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its p...

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a privately held company based in Bedford, MA, focused on the development and commercialization of ophthalmic therapeutic products using its proprietar...

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the ...

More Information about "C T O CLINICA TERAPUTICA OCULAR" on BioPortfolio

We have published hundreds of C T O CLINICA TERAPUTICA OCULAR news stories on BioPortfolio along with dozens of C T O CLINICA TERAPUTICA OCULAR Clinical Trials and PubMed Articles about C T O CLINICA TERAPUTICA OCULAR for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of C T O CLINICA TERAPUTICA OCULAR Companies in our database. You can also find out about relevant C T O CLINICA TERAPUTICA OCULAR Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record